Dayaker Gagadam, M.D.
Critical Care Medicine (Internal Medicine) Physician in Fort Worth, Texas. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,631 in Critical Care Medicine (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Dayaker Gagadam, M.D. reported a CMS MIPS final score of 17.4/100 - below the 83.1 national average - and filed 2,912 Medicare Part D claims in 2023.
- 17.4/100
- MIPS score · -66 vs avg
- 3K
- Part D claims, 2023
- 29%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Dayaker Gagadam, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
17 2nd percentile higher than 2% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Dayaker Gagadam, M.D. sits
This provider among critical care medicine (internal medicine) physician peers
Across the 1,643 critical care medicine (internal medicine) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Dayaker Gagadam, M.D. writes more Part D claims than 89% of them and scores higher on MIPS quality than 2% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one critical care medicine (internal medicine) physician peer from a representative sample of 60; the gold marker is Dayaker Gagadam, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Dayaker Gagadam, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Dayaker Gagadam, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Critical Care Medicine (Internal Medicine) Physician compares to other specialties among Texas providers
Largest specialties in Texas (% of in-state providers)
Critical Care Medicine (Internal Medicine) Physician ranks #108 among Texas's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Critical Care Medicine (Internal Medicine) Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Dayaker Gagadam, M.D.'s 2023 MIPS final score plotted against the Critical Care Medicine (Internal Medicine) Physician national average
- MIPS Final Score
- 17.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Critical Care Medicine (Internal Medicine) Physician) - 17.4/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Critical Care Medicine (Internal Medicine) Physician US NPIs
17.4/100 MIPS final score - 65.7 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Critical Care Medicine (Internal Medicine) Physician. Quality dim: 0. Cost dim: 58.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Dayaker Gagadam, M.D. appears in the CMS NPPES registry as a Critical Care Medicine (Internal Medicine) Physician provider holding M.D. credentials at 923 COLLEGE AVE STE 103, Fort Worth, TX, 76104, with a listed phone of (817) 293-3000. NPI 1093765729 was issued on 05/11/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Gagadam most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,912 prescription claims written by this provider, covering 417 Medicare beneficiaries and totaling roughly $1.7 million in drug spend, split 71% brand-name and 29% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 17.4/100 for the 2023 performance year (Quality 0, Cost 58), compared with the national average of 83.1.
Critical Care Medicine (Internal Medicine) Physician is a mid-sized specialty nationwide, with 6,631 enrolled providers across 53 states and an average of 1,069 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1093765729 |
|---|---|
| Specialty | Critical Care Medicine (Internal Medicine) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/11/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Dayaker Gagadam, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Dayaker Gagadam, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.9K
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Dayaker Gagadam, M.D.. To verify Dayaker Gagadam, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
71% brand-name claims vs 29% generic, on 2,912 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,467
- Total Day Supply
- 97,301
- Brand vs Generic
- 71% brand / 29% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $49K
- Antibiotic Claims
- 86
Patient Demographics
- Average Patient Age
- 70.8 years
- Avg HCC Risk Score
- 2.58
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 68, 65-74: 202, 75-84: 117, 85+: 30
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Dayaker Gagadam, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Albuterol Sulfate …
Albuterol Sulfate Hfa
715 claims
- Trelegy Ellipta
Trelegy Ellipta
380 claims
- Breztri Aerosphere 224
Breztri Aerosphere
224 claims
- Anoro Ellipta 164
Anoro Ellipta
164 claims
- Breo Ellipta 146
Breo Ellipta
146 claims
- Symbicort 136
Symbicort
136 claims
- Stiolto Respimat 132
Stiolto Respimat
132 claims
- Montelukast Sodium 104
Montelukast Sodium
104 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 715 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 380 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 224 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 164 |
| Breo Ellipta Fluticasone/Vilanterol | 146 |
| Symbicort Budesonide/Formoterol Fumarate | 136 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 132 |
| Montelukast Sodium | 104 |
| Prednisone | 84 |
| Ventolin Hfa Albuterol Sulfate | 78 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Critical Care Medicine (Internal Medicine) Physician Overview
How Dayaker Gagadam, M.D. fits within the Critical Care Medicine (Internal Medicine) Physician landscape nationally.
Dayaker Gagadam, M.D.'s 2,912 claims are above the specialty average of 1,069.
Nearby Critical Care Medicine (Internal Medicine) Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Gagadam.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Critical Care Medicine (Internal Medicine) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is Dayaker Gagadam, M.D.'s specialty? ▼
How much does Dayaker Gagadam, M.D. prescribe under Medicare Part D? ▼
What is Dayaker Gagadam, M.D.'s Medicare quality score? ▼
Where is Dayaker Gagadam, M.D. located? ▼
What is Dayaker Gagadam, M.D.'s NPI number? ▼
Does Dayaker Gagadam, M.D. prescribe more brand-name or generic drugs? ▼
How many Critical Care Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does Dayaker Gagadam, M.D. prescribe most often? ▼
Does Dayaker Gagadam, M.D. accept Medicare? ▼
How can I verify Dayaker Gagadam, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology